RxSight, Inc. · 20 hours ago
Analyst, Corporate Strategy & Development
RxSight, Inc. is an ophthalmic medical technology corporation focused on revolutionizing cataract surgery. The Analyst, Corporate Strategy & Development will support enterprise strategy and corporate development initiatives, providing analysis, financial modeling, and materials to aid senior leadership decision-making.
BiotechnologyEyewearHealth CareMedical Device
Responsibilities
Support the end-to-end lifecycle of corporate development initiatives
Assist in the evaluation of partnerships, licensing opportunities, collaborations, and other growth initiatives across U.S. and international markets
Conduct detailed commercial, market, and strategic analyses, including market sizing, unmet need, competitive dynamics, and strategic fit assessments
Coordinate and support cross-functional diligence efforts in partnership with Legal, Finance, R&D, Commercial, Regulatory, and external advisors
Build financial models and business cases to assess valuation, ROI, risk, and strategic impact of potential opportunities
Support preparation of internal materials, decision memoranda, and executive updates used in investment and partnership decisions
Support RxSight’s enterprise and functional strategic planning processes, including enterprise strategy development, market entry evaluation, and portfolio expansion initiatives
Provide high-leverage analytical and execution support to the Senior Manager and senior executives on high-priority strategic initiatives
Partner cross-functionally with Commercial, R&D, Finance, and Operations teams to drive alignment and execution of strategic priorities
Coordinate and synthesize cross-functional inputs to support executive decision-making, including preparation of executive and Board of Directors strategy materials related to enterprise strategy and corporate development initiatives
Build dashboards and track progress, key milestones, risks, and interdependencies across strategic initiatives to support execution discipline and accountability
Conduct structured analyses of industry trends, competitive dynamics, and strategic opportunities relevant to RxSight’s long-term objectives
Build financial, strategic, and scenario models to support prioritization, resource allocation, and strategic decision-making
Synthesize complex qualitative and quantitative insights into clear, concise, executive-ready presentations for senior leadership
Qualification
Required
Strong analytical and problem-solving skills with the ability to structure ambiguous, open-ended strategic problems
Solid understanding of core business, strategy, and finance concepts, including market analysis, valuation, ROI, and scenario modeling
Ability to synthesize complex information into concise, executive-level recommendations
Strong financial acumen and comfort building and interpreting financial models
Excellent written and verbal communication skills, particularly in developing high-quality PowerPoint presentations
High attention to detail, strong ownership mindset, and ability to manage multiple workstreams simultaneously
Strong interpersonal skills and comfort working cross-functionally with senior leaders
Professional judgment and discretion when handling sensitive strategic and transactional information
Bachelor's degree in Business, Economics, Finance, Engineering, Life Sciences, or a related analytical discipline, with a strong academic record demonstrating analytical rigor
1–4 years of relevant experience in management consulting, investment banking, corporate strategy, corporate development, equity research, or related analytical roles (including internships or rotational programs)
Advanced proficiency in Microsoft Excel, including financial modeling and scenario analysis
Advanced proficiency in Microsoft PowerPoint
Proficiency in Microsoft Word
Preferred
Healthcare, MedTech, or life sciences experience preferred but not required
Familiarity with data visualization or analytics tools (e.g., Tableau, Power BI) a plus
Company
RxSight, Inc.
RxSight® is an ophthalmic medical technology corporation headquartered in Aliso Viejo, California that has commercialized the world’s first and only adjustable intraocular lens (IOL) that is customized after cataract surgery.
Funding
Current Stage
Public CompanyTotal Funding
$350.98MKey Investors
Oxford Finance LLCBiomedical Advanced Research and Development Authority (BARDA)Visionary Venture Fund
2024-05-08Post Ipo Equity· $115M
2023-02-07Post Ipo Equity· $50M
2021-07-29IPO
Leadership Team
Ron Kurtz
Co-President and CEO
R
Robert Grubbs
Co-Founder
Recent News
Orange County Business Journal
2026-01-22
2026-01-20
Orange County Business Journal
2026-01-14
Company data provided by crunchbase